Back to Search
STEPHEN DALRYMPLE, MD
MD
Specialist
NPI: 1265473516IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
9500875(NC)
CMS Specialties
PrimaryNEUROSURGERY
Education
GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1988
Research & Publications (20)
The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts.
PMID 17373719·Prostate·2007
7-preclinical
Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.
PMID 16230388·Cancer Res·2005
8-other
p38 mitogen activated protein kinase as a therapeutic target for Alzheimer's disease.
PMID 12540055·J Mol Neurosci·2002
6-review
Crystallization and preliminary X-ray studies of the N-domain of the Wilson disease associated protein.
PMID 19478447·Acta Crystallogr Sect F Struct Biol Cryst Commun·2009
8-other
Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells.
PMID 19417145·Mol Cancer Ther·2009
7-preclinical
Detection and quantification of the evolution dynamics of apoptosis using the PET voltage sensor 18F-fluorobenzyl triphenyl phosphonium.
PMID 19372481·J Nucl Med·2009
8-other
The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
PMID 19047148·Cancer Res·2008
7-preclinical
Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer.
PMID 18670647·Neoplasia·2008
8-other
Crystal engineering of a permanently porous network sustained exclusively by charge-assisted hydrogen bonds.
PMID 17880091·J Am Chem Soc·2007
8-other
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase.
PMID 17154430·ChemMedChem·2007
7-preclinical
Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells.
PMID 17015840·Proc Natl Acad Sci U S A·2006
4-observational
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
PMID 16955399·Prostate·2006
7-preclinical
Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.
PMID 16951173·Cancer Res·2006
8-other
CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo.
PMID 16891455·Mol Cancer Ther·2006
7-preclinical
Evaluation of antitumor properties of novel saframycin analogs in vitro and in vivo.
PMID 16870445·Bioorg Med Chem Lett·2006
7-preclinical
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
PMID 16835890·Prostate·2006
7-preclinical
Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
PMID 16818707·Clin Cancer Res·2006
7-preclinical
CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo.
PMID 16731764·Mol Cancer Ther·2006
7-preclinical
Benzoylphenylurea sulfur analogues with potent antitumor activity.
PMID 16570932·J Med Chem·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 722 NEWMAN RD
NEW BERN, NC 28562 - Phone
- (252) 638-4500
Quick Facts
- NPI
- 1265473516
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile